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Planning and 
conducting a 
research survey
ANN MOORMANN, PHD, MPH
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
Why would I do a survey?
 To measure or assess the relationship between past 
exposures and a disease or health outcome. 
To create a data record for later analysis
As a first step, define your hypothesis based on the 
research question and then decide which study 
design will be best suitable to answer that question.
 Is your study observational or experimental?
Observational: Case Control Study
 A survey can be used to determine the degree of 
association between various risk factors and outcomes.  
 Cases have the disease outcome of interest when 
enrolled in study
 Controls do not have the disease of interest when 
enrolled in study
 A survey is a data collection tool that provides a 
retrospective assessment of exposures.
 Exposures can be harmful or beneficial.
Benefits and limitations of 
case-control studies
 Good for rare diseases that take a long time to develop
 Relatively inexpensive
 Quick – since you don’t have to wait for disease to occur
 Limitations – recall bias or insufficient records of past 
exposures
 Does not prove causality but can provide evidence for a 
significant association between exposure and outcome.
Survey type and data source
Subjective sources
 Survey types used to find out which questions to ask
 Focus group discussion
 Key informant interviews
 Individual Questionnaire to record exposures
 Interview study participant (or parent of minor)
Objective sources
 Medical record extraction including clinical lab values
 Blood test (if exposure can persist in the body, such as drug 
levels to see if patient compliant with a treatment regimen)
Observational: Cohort study
 Study participants are selected based on EXPOSURE
of interest (exposed versus non-exposed)
 Both groups followed over time to determine how 
many develop the disease or outcome of interest.
 Longitudinal study design – length of observation 
time determined by disease or outcome of interest.
 Can be prospective or retrospective
Benefits and limitations of 
cohort studies
 Good for common diseases or outcomes that don’t take 
a long time to develop
 Supports a causal link between exposure and disease 
outcome (relative risk)
 Limitations – takes time to complete study (can be years 
of data collection), more expensive, needs consistent and 
robust data collection team to prevent operator bias.
Survey types and data source
Objective outcome measurement
 Diagnostic test to confirm disease outcome
 If exposure time was definitive, able to assess progression of 
disease (how long it takes from exposure to disease 
presentation)
 More than one outcome can be assessed if exposure is 
suspected to cause multiple diseases
Observational: Cross-sectional study
 Measures both exposure and outcome at one 
time for individuals(snap shot)
 Determines prevalence of exposure and disease 
(scope of the problem and suspected causes)
 Quick and easy to do
 Limitation - cannot conclude cause-effect 
relationship between exposure and outcome
Observational: Ecological study
 Measures both exposure and outcome at one time 
for a population (snap shot)
 Determines prevalence of exposure and disease 
(scope of the problem within a community and 
suspected causes)
 Quick and easy to do (large scale)
 Limitation - cannot conclude cause-effect 
relationship between exposure and outcome
 Beware of ecological fallacy (attributing population 
level data to individuals)
Survey type and data source
Objective sources
 Population level databases, if available (some examples)
 cancer or other disease prevalence registry
 pollution records
 introduction of a product, extent of use and availability, etc.
 Census records
Experimental: Randomized clinical trial
 Study participants randomized to control group or 
experimental group
 Both groups followed over time to determine how 
many achieve the outcome of interest
 Longitudinal study design – length of observation 
time determined by outcome of interest.
 Prospective in nature – considered GOLD 
STANDARD as it proves cause-effect relationship
Benefits and limitations of clinical trials
 Demonstrates causal link between intervention and disease 
outcome (i.e. survival analysis for treatment studies or 
protection from disease for vaccine studies)
 Avoids confounding and selection bias
 Limitations – takes time to complete study, most expensive, 
needs consistent and robust data collection team to prevent 
operator bias and monitors for severe adverse events.
 Study participant refusal, crossover, drop outs and lack of 
compliance
Survey types and data source
Objective exposure and outcome measurements
 Controlled intervention (i.e. drug treatment or vaccine)
 Robust diagnostic test to confirm disease or outcome
 Since exposure is pre-determined, able to conclusively assess 
how long it takes from exposure to achieve outcome
 Can determine benefit of intervention compared to no 
intervention on health outcomes
 Cost-benefit analysis
Paperless data collection
 RedCap (https://en.wikipedia.org/wiki/REDCap)
Research Electronic Data Capture
Ensures security and protection of health data linked to a 
study participant
Free – but password protected
Developed by Vanderbilt in 2004
Used by 2400 institutional partners in over 115 countries, with more than 590,000 
total end-users employing the software for more than 450,000 ongoing research 
studies.[2]
What types of data do you want to collect 
and how do you make sure it’s accurate?
Designing your data collection/survey tool
Demographic data 
(protected health information)
 Name
 Date of birth
 Date of survey
 Sex (different from gender)
 Home location
 Name of family members (spouse or parents of minors)
21 variables considered PHI = can this data be used to identify a study 
participant?
https://en.wikipedia.org/wiki/Protected_health_information
sources
 https://www.ncbi.nlm.nih.gov/books/NBK470342/
